CDEK by Data4ThePeople

Sign in Sign up

← All drugs Report issue

leucettinib-21

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Dual-specificity tyrosine-phosphorylation regulated kinase 1AINHIBITOR
DYRK1A inhibitor
- Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) ↗

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No